Australia's largest stock trading and investment forum Australia's #1 stock forum

IBX

0.00%

4.0¢ imagion biosystems limited

They already know that they won’t get IND approval because their...

First 8 Last

Share
Profile

Follow
jackherb

725 Posts.

121

31/08/24

01:32

Post #: 75466415
Share

Originally posted by austrader26: ↑

Fantastic Report, Bob. As in, beyond belief.

Who would have thought, spending like drunken sailors for literally years has depleted reserved to dangerously low levels.

"In addition to funding available through the Mercer facility, the consolidated entity expects to initiate an entitlementoffer to raise capital before the end of the third quarter of 2024 to assist in providing liquidity for the Company andadvance the clinical development of its lead MagSense® imaging agent towards an IND filing and for a multi-site Phase 2study in the US.If the consolidated entity’s capital raising efforts are not successful to adequately fund the Company’s near-termactivities, the Company may need to cease operation."

It was a little unclear. Is that another CR in the current Quarter, just to keep the lights on? What hope is there to progress the Phase 2/IND Filing, given that most staff have been let go?

Looks like they're going to fake it all the way into the ground.

GLTAH. DYOR.

Expand

They already know that they won’t get IND approval because their first basic little trial failed.
They just want more money to pay their their wages and buy them time while they look for jobs elsewhere. Who would be dumb enough to take them on.

IBX Price at posting: 3.6¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 1 more message in this thread...

First 8 Last

Add IBX (ASX) to my watchlist

(20min delay)
Last 4.0¢		Change 0.000(0.00%)		Mkt cap ! $1.425M

Open	High	Low	Value	Volume
4.0¢	4.0¢	3.6¢	$27.63K	750.1K

Buyers (Bids)

No.	Vol.	Price($)
2	63865	3.7¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	25000	1

View Market Depth

No.	Vol.	Price($)
2	63865	0.037
1	28571	0.035
1	20000	0.034
2	48750	0.033
1	92000	0.032

Price($)	Vol.	No.
0.046	90637	1
0.047	14800	1
0.048	13016	2
0.050	105885	2
0.055	88714	1

Last trade - 13.05pm 04/10/2024 (20 minute delay)

IBX (ASX) Chart

They already know that they won’t get IND approval because their...

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

They already know that they won’t get IND approval because their...

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News